on Illumipure
IllumiPure Successfully Completes First National Medical Installations of CleanWhite LED Solutions
Houston, TX / ACCESSWIRE / June 25, 2024 / illumiPure, a leader in innovative LED solutions, has announced the successful completion of its initial healthcare installations of CleanWhite LED lighting systems at Glendale Surgical Associates in Glendale, California, and West Chase Houston Hospital in Houston, Texas. These installations mark a significant advancement in healthcare lighting technology, offering substantial benefits to both healthcare providers and their patients.
CleanWhite LEDs provide superior illumination, incorporate advanced disinfection capabilities, and eliminate harmful blue light. This innovative solution enhances the visual environment and contributes to a safer and healthier setting for patients and staff.
Dr. Jeffrey Hammoudeh, a renowned surgeon at Glendale Surgical Associates, expressed his satisfaction with the CleanWhite installation, stating that it positively impacted the facility's atmosphere. The staff and patients feel safer, and the overall environment has improved significantly, making it a worthwhile investment.
Similarly, West Chase Houston Hospital has embraced the CleanWhite technology, becoming the first healthcare facility in Houston to use these disinfection fixtures. Their Quality Coordinator, Tresa, emphasized the improved health benefits and reduced eye strain among staff and patients since the installation.
John Higgins, CEO of illumiPure, highlighted the strategic importance and competitive pricing of CleanWhite fixtures, stressing their role in combating antimicrobial diseases and reducing harmful blue light. These successful installations reinforce illumiPure's commitment to enhancing healthcare environments with state-of-the-art lighting solutions.
R. P.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Illumipure news